Medeon Biodesign Stock Market Capitalization
| 6499 Stock | TWD 42.45 0.50 1.16% |
Medeon Biodesign fundamentals help investors to digest information that contributes to Medeon Biodesign's financial success or failures. It also enables traders to predict the movement of Medeon Stock. The fundamental analysis module provides a way to measure Medeon Biodesign's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medeon Biodesign stock.
Medeon |
Medeon Biodesign Company Market Capitalization Analysis
Medeon Biodesign's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Medeon Biodesign Market Capitalization | 5 B |
Most of Medeon Biodesign's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medeon Biodesign is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Medeon Biodesign is about 5 B. This is 61.4% lower than that of the Healthcare sector and 39.69% lower than that of the Medical Instruments & Supplies industry. The market capitalization for all Taiwan stocks is 73.75% higher than that of the company.
Medeon Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medeon Biodesign's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medeon Biodesign could also be used in its relative valuation, which is a method of valuing Medeon Biodesign by comparing valuation metrics of similar companies.Medeon Biodesign is currently under evaluation in market capitalization category among related companies.
Medeon Fundamentals
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0639 | |||
| Profit Margin | (1.31) % | |||
| Operating Margin | (1.64) % | |||
| Current Valuation | 3.37 B | |||
| Shares Outstanding | 87.64 M | |||
| Shares Owned By Insiders | 50.07 % | |||
| Shares Owned By Institutions | 4.65 % | |||
| Price To Book | 1.29 X | |||
| Price To Sales | 19.67 X | |||
| Revenue | 68.96 M | |||
| Gross Profit | 28.63 M | |||
| EBITDA | (453.87 M) | |||
| Net Income | 2.08 B | |||
| Book Value Per Share | 43.26 X | |||
| Cash Flow From Operations | (293.38 M) | |||
| Earnings Per Share | 30.41 X | |||
| Number Of Employees | 16 | |||
| Beta | 0.79 | |||
| Market Capitalization | 5 B | |||
| Total Asset | 4.36 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 4.36 B | |||
| Last Dividend Paid | 0.83 |
About Medeon Biodesign Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medeon Biodesign's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medeon Biodesign using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medeon Biodesign based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medeon Biodesign in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medeon Biodesign's short interest history, or implied volatility extrapolated from Medeon Biodesign options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medeon Biodesign. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Medeon Stock analysis
When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |